AI Article Synopsis

  • The study explores mutations in unrelated Czech and British families with posterior polymorphous corneal dystrophy (PPCD), a rare eye disorder.
  • Four novel pathogenic mutations were found in the ZEB1 gene across four families, including deletions, a nonsense mutation, and a duplication.
  • No disease-causing mutations were identified in six other families, suggesting that additional unidentified genes may contribute to PPCD.

Article Abstract

We describe the search for mutations in six unrelated Czech and four unrelated British families with posterior polymorphous corneal dystrophy (PPCD); a relatively rare eye disorder. Coding exons and intron/exon boundaries of all three genes (VSX1, COL8A2, and ZEB1/TCF8) previously reported to be implicated in the pathogenesis of this disorder were screened by DNA sequencing. Four novel pathogenic mutations were identified in four families; two deletions, one nonsense, and one duplication within exon 7 in the ZEB1 gene located at 10p11.2. We also genotyped the Czech patients to test for a founder haplotype and lack of disease segregation with the 20p11.2 locus we previously described. Although a systematic clinical examination was not performed, our investigation does not support an association between ZEB1 changes and self reported non-ocular anomalies. In the remaining six families no disease causing mutations were identified thereby indicating that as yet unidentified gene(s) are likely to be responsible for PPCD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696796PMC
http://dx.doi.org/10.1002/humu.9495DOI Listing

Publication Analysis

Top Keywords

zeb1 gene
8
posterior polymorphous
8
polymorphous corneal
8
corneal dystrophy
8
mutations identified
8
novel mutations
4
mutations zeb1
4
gene identified
4
identified czech
4
czech british
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!